Bioregenx BRGX
OTC BRGX
$0.00 +0.00 (+0.00%)
At close: Oct 19, 2026 · 4:00 PM EDT

Bioregenx, Inc. (BRGX) Current Deferred Revenue (2023 - 2026)

Updated

Bioregenx (BRGX) posted Current Deferred Revenue of $56,528 for Q1 2026, down 70.1% from $189,282 a year earlier and down 6.1% from the prior quarter.

Analysis

Bioregenx, Inc. (BRGX) Current Deferred Revenue (2023 - 2026) Analysis & Trends

At the end of FY2025, Bioregenx's Current Deferred Revenue came in at $60,227, down 69.4% from FY2024.

  • In prior years, Bioregenx's Current Deferred Revenue was $197,027 in FY2024 (-44.4%) and $354,203 in FY2023.
  • The Q1 2026 figure stands as the lowest quarterly Current Deferred Revenue in data going back to Q4 2023.
  • On a year-over-year basis, Current Deferred Revenue has declined in each of the last six quarters, with an average decline of 51.0% over the last six quarters.
  • According to Business Quant data, Current Deferred Revenue for the three prior quarters was $60,227 (Q4 2025), $95,773 (Q3 2025) and $125,174 (Q2 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 56,528.00
Dec 31, 2025 60,227.00
Sep 30, 2025 95,773.00
Jun 30, 2025 125,174.00
Mar 31, 2025 189,282.00
Dec 31, 2024 197,027.00
Sep 30, 2024 165,574.00
Jun 30, 2024 195,938.00
Mar 31, 2024 334,939.00
Dec 31, 2023 354,203.00
API Access

Bioregenx, Inc. Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=BRGX&period=max&api_key=YOUR_API_KEY